CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer.

Brodkin J, Kaprio T, Mustonen H, Leppä A, Kokkola A, Salmi M, Jalkanen S, Haglund C, Böckelman C

Open source

DOI
10.1038/s41598-026-46511-z
Published
2026 Mar 29
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-46511-z,
  title = {CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer.},
  author = {Brodkin J and Kaprio T and Mustonen H and Leppä A and Kokkola A and Salmi M and Jalkanen S and Haglund C and Böckelman C},
  year = {2026},
  journal = {Scientific reports},
  doi = {10.1038/s41598-026-46511-z},
  url = {https://doi.org/10.1038/s41598-026-46511-z}
}

RIS

TY  - JOUR
TI  - CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer.
AU  - Brodkin J
AU  - Kaprio T
AU  - Mustonen H
AU  - Leppä A
AU  - Kokkola A
AU  - Salmi M
AU  - Jalkanen S
AU  - Haglund C
AU  - Böckelman C
PY  - 2026
JO  - Scientific reports
DO  - 10.1038/s41598-026-46511-z
UR  - https://doi.org/10.1038/s41598-026-46511-z
ER  - 

APA

J, B., T, K., H, M., A, L., A, K., M, S., S, J., C, H., & C, B. (2026). CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer.. Scientific reports. https://doi.org/10.1038/s41598-026-46511-z

Source records